K072039 is an FDA 510(k) clearance for the ADVOCATE REDI-CODE BLOOD GLUCOSE MONITORING SYSTEM, MODELS TD-4223E. This device is classified as a System, Test, Blood Glucose, Over The Counter (Class II - Special Controls, product code NBW).
Submitted by Taidoc Technology Corporation (San Chung, Taipei, TW). The FDA issued a Cleared decision on October 3, 2007, 70 days after receiving the submission on July 25, 2007.
This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1345.